Pharmacoeconomic review report. Empagliflozin (Jardiance).
Empagliflozin (Jardiance) is a once-daily oral antidiabetic drug belonging to the sodium glucose cotransporter-2 (SGLT-2) inhibitor class. It promotes urinary glucose excretion. This review by the CADTH Common Drug Review (CDR) will focus on the following indication: 1. For adults with type 2 diabet...
Saved in:
| Online Access: |
http://www.ncbi.nlm.nih.gov/books/NBK533798/ Full text |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Ottawa (ON) :
CADTH,
2015
|
| Series: | Common drug review clinical review report.
|
| Subjects: |
Search Result 1
Full text
Pharmacoeconomic review report. Apomorphine (Movapo) (Paladin Labs, Inc.)
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 2
Full text
Pharmacoeconomic review report. Cysteamine delayed-release capsules (Procysbi), Horizon Pharma Ireland Ltd.
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 3
Pharmacoeconomic review report. Dexamethasone (Ozurdex) (Allergan Inc.).
Final with redactions.
Published 2018
Full text
Electronic
eBook
Search Result 4
Pharmacoeconomic review report. Dupilumab (Dupixent) (Sanofi-Aventis Canada Inc.).
Final Pharmacoeconomic Review Report (with redactions).
Published 2018
Full text
Electronic
eBook
Search Result 5
Full text
Pharmacoeconomic review report. Glecaprevir / pibrentasvir (Maviret) (AbbVie corporation).
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 6
Full text
Pharmacoeconomic review report. Guselkumab (Tremfya) (Janssen Inc.).
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 7
Pharmacoeconomic review report. Letermovir (Prevymis) (Merck Canada Inc.).
Final pharmacoeconomic review report (with redactions).
Published 2018
Full text
Electronic
eBook
Search Result 8
Full text
Pharmacoeconomic review report. Migalastat (Galafold) (Amicus therapeutics).
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 9
Full text
Pharmacoeconomic review report. Netupitant/Palonosetron 300 mg/0.5 mg (Akynzeo) (Purdue pharma).
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 10
Full text
Pharmacoeconomic review report. Nitisinone (MDK-Nitisinone) (MendeliKABS inc.).
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 11
Full text
Pharmacoeconomic review report. Nitisinone (Orfadin) (Sobi Canada Inc.).
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 12
Full text
Pharmacoeconomic review report. Nusinersen (Spinraza) (Biogen Canada Inc.).
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 13
Full text
Pharmacoeconomic review report. Ocrelizumab (Ocrevus) (Hoffmann-La roche limited).
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 14
Search Result 15
Pharmacoeconomic review report. Sebelipase Alfa (Kanuma) (Alexion pharmaceuticals, Inc.).
Published 2018
Full text
Electronic
eBook
Search Result 16
Full text
Pharmacoeconomic review report. Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.).
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 17
Full text
Pharmacoeconomic review report. Tenofovir alafenamide (Vemlidy) (Gilead Sciences Canada, Inc.).
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 18
Full text
Pharmacoeconomic review report. Tocilizumab (Actemra) (Hoffman-La Roche Limited).
Published 2018
Get full text
Full text
Electronic
eBook
Search Result 19
Full text
Pharmacoeconomic review report. AbobotulinumtoxinA (Dysport therapeutic) (Ipsen Biopharmaceuticals Canada, Inc.).
Published 2017
Get full text
Full text
Electronic
eBook
Search Result 20
Full text
Pharmacoeconomic review report. Daclizumab (Zinbryta).
Published 2017
Get full text
Full text
Electronic
eBook
